.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Julphar
Citi
Teva
AstraZeneca
Daiichi Sankyo
Queensland Health
Baxter
Chubb
Covington

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018044

« Back to Dashboard
NDA 018044 describes ROCALTROL, which is a drug marketed by Validus Pharms and is included in two NDAs. It is available from seven suppliers. Additional details are available on the ROCALTROL profile page.

The generic ingredient in ROCALTROL is calcitriol. There are ten drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the calcitriol profile page.

Summary for 018044

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 018044

Ingredient-typeCholecalciferol

Medical Subject Heading (MeSH) Categories for 018044

Suppliers and Packaging for NDA: 018044

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ROCALTROL
calcitriol
CAPSULE;ORAL 018044 NDA KAISER FOUNDATION HOSPITALS 0179-0063 0179-0063-70 30 CAPSULE, GELATIN COATED in 1 BOX, UNIT-DOSE (0179-0063-70)
ROCALTROL
calcitriol
CAPSULE;ORAL 018044 NDA KAISER FOUNDATION HOSPITALS 0179-0069 0179-0069-70 30 CAPSULE, GELATIN COATED in 1 BOX, UNIT-DOSE (0179-0069-70)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.25MCG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.5MCG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 018044

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms
ROCALTROL
calcitriol
CAPSULE;ORAL018044-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Validus Pharms
ROCALTROL
calcitriol
CAPSULE;ORAL018044-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Validus Pharms
ROCALTROL
calcitriol
CAPSULE;ORAL018044-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Validus Pharms
ROCALTROL
calcitriol
CAPSULE;ORAL018044-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Validus Pharms
ROCALTROL
calcitriol
CAPSULE;ORAL018044-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Validus Pharms
ROCALTROL
calcitriol
CAPSULE;ORAL018044-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Validus Pharms
ROCALTROL
calcitriol
CAPSULE;ORAL018044-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Validus Pharms
ROCALTROL
calcitriol
CAPSULE;ORAL018044-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Colorcon
Fuji
AstraZeneca
Cerilliant
Medtronic
Argus Health
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot